Antimalarials may reduce cancer risk in patients with systemic lupus erythematosus: a systematic review and meta-analysis of prospective studies.

Ann Med · 2021 · PMC8462850 · PMID 34553648

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In a previous study with 14 cohorts, a reduced risk (adjusted hazard ratios = 0.55) was observed for lung cancer in SLE patients with cumulative use of antimalarial drugs over 5 years but did not reach statistical significance [ 34 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.